Aker BioMarine ASA – Successful placement of senior secured bonds

29 Aug 2024 15:49 CEST

29 August 2024: Aker BioMarine ASA ("AKBM") has successfully completed a new
bond issue of NOK 1,600 million, carrying a coupon of 3 months NIBOR +4.25% p.a.
with quarterly interest payments. The bond issue was oversubscribed.

The net proceeds from the bond issue, together with proceeds from the sale of
the Feed Ingredients business, will be employed towards refinancing of existing
debt, distributing an extraordinary dividend and general corporate purposes.

Arctic Securities, DNB Markets and Nordea acted as Joint Lead Managers in
connection with the placement of the new bond issue.


For further information, please contact
Christopher Robin Vinter, VP IR & Corporate Finance
Mobile: +47 911 60 820
Email: Christopher.vinter@akerbiomarine.com

About Aker BioMarine
Aker BioMarine is a leading biotech innovator and Antarctic krill-harvesting
company developing krill-derived products for consumer health and wellness as
well as animal nutrition. The company has a strong position in its industry and
is the world's leading supplier of krill, the natural, powerful and health
promoting source of nutrients from the pristine waters of Antarctica. Aker
BioMarine is listed on Oslo Stock Exchange (AKBM). More information is available
at www.akerbiomarine.com.

More information:
Access the news on Oslo Bors NewsWeb site